CATALENT, INC.
CTLT Real Time Price USDRecent trades of CTLT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CTLT's directors and management
Government lobbying spending instances
-
$60,000 Oct 19, 2022 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$60,000 Jul 20, 2022 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$60,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$60,000 Jan 20, 2022 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$60,000 Oct 19, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$60,000 Jul 16, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$20,000 Mar 10, 2017 Issue: Health Issues
-
$20,000 Apr 19, 2016 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CTLT in WallStreetBets Daily Discussion
Recent insights relating to CTLT
Recent picks made for CTLT stock on CNBC
ETFs with the largest estimated holdings in CTLT
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CTLT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.